significantly improved and was sustained over the 2 year(P<0.05) followup. Temporary paraesthesia was found in 11% which completely resolved. No major complications occurred. Conclusion: Early and mid-term results of EVLA for SSV incompetence demonstrated this treatment to be safe and effective. Clinical recurrence due to recanalisation may occur despite adequate magnitude of energy delivery; neoreflux in previously competent veins may contribute to this process.
1 Great Ormond Street Hospital, London, UK; 2 Royal Free Hampstead NHS Trust, London, UK Aim: Mid-aortic syndrome (MAS) is a cause of severe hypertension in children. It is essential to make an early diagnosis. We undertook a retrospective study to assess the benefit of endovascular techniques in the treatment of MAS and the importance of a multi-disciplinary team (MDT) approach. Methods: A retrospective review of 22 patients treated by radiological intervention at Great Ormond Street Hospital. Results: 49 procedures (mean 2.2 procedures: range 1-5) were undertaken on 22 patients (mean age 7.6 years: 14 boys (64%) and 8 girls (36%)). Complications were seen in four cases including one death due to haemorrhage following angioplasty, 2 pseudoaneuryms and one urethral trauma. Radiological intervention followed surgery in 23% (5/22) of cases. 9% were 'cured' (2/22), 60% 'improved' with fewer medications or symptoms, 27% had no change and 4% 'failed.' Conclusion: Radiological intervention provides a viable treatment method for MAS, although it may not be definitive and is not without complications. Surgery is often used as a final intervention but can be used in conjunction with or prior to radiological techniques. An individualized and combined treatment plan for each patient by an MDT comprising radiological, surgical and medical specialties is essential to improve outcome in MAS patients. (QoL) to inform decisions on health resource provision; Superficial Venous Insufficiency (SVI) has a significant negative effect on QoL. Some medical insurance companies require a minimum GSV diameter before funding intervention for SVI. The aim of this study was to assess the ability of GSV diameter to accurately predict clinical severity and QoL in patients with SVI. Methods: A prospectively maintained database of patients with primary, symptomatic SVI was interrogated. Pre-procedural duplex ultrasound measurements of GSV diameter were correlated with clinical severity (CEAP and VCSS), generic and disease-specific QoL using Spearman's rho correlation coefficient. Results: 493 patients (64% female, mean age 49 [S.D. 14] years) were assessed prior to planned intervention. There were weak but statistically significant correlations between increasing GSV diameter and CEAP (r¼.302, p<0.01), VCSS (r¼.239, p<0.001) and AVVQ (r¼.101, p<0.05) but not with generic QoL. Conclusions: There is a complex interplay between factors that affect QoL in SVI, with no obvious single surrogate marker. Detailed regression analyses may further elucidate these relationships. Provision of intervention in SVI should currently be based on patient symptoms and QoL in combination with detailed clinical and ultrasonographic assessment. within 12/12 and another 2% stenosed after a year. Lifetime amputation rate was 11%. When analysed according to operation, 64% underwent fem-pop bypass (88% 1 year patency, 12% stenosis), 21% fem-distal bypass (88% patency, 11% stenosis), 6% pop-distal bypass (80% patency, 20% stenosis) and 9% other bypass. The majority of fem-pop associated complications (50%) were identified at 6/12, with another 19% arising after surveillance completion. There was no pattern to stenosis/occlusion
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